This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Aug 1;167(3):202-203.

doi: 10.7326/M17-1565. Epub 2017 Jul 4.

Fool Me Thrice: The Evolving Story of Multiply Recurrent Clostridium difficile Infection

Sameer D Saini¹, Akbar K Waljee¹

Affiliations

PMID: 28672286
DOI: 10.7326/M17-1565

Comment

Fool Me Thrice: The Evolving Story of Multiply Recurrent Clostridium difficile Infection

Sameer D Saini et al. Ann Intern Med. 2017.

. 2017 Aug 1;167(3):202-203.

doi: 10.7326/M17-1565. Epub 2017 Jul 4.

Authors

Sameer D Saini¹, Akbar K Waljee¹

Affiliation

¹ From VA Ann Arbor Center for Clinical Management Research and University of Michigan, Ann Arbor, Michigan.

PMID: 28672286
DOI: 10.7326/M17-1565

No abstract available

PubMed Disclaimer

Comment on

Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study.
Ma GK, Brensinger CM, Wu Q, Lewis JD. Ma GK, et al. Ann Intern Med. 2017 Aug 1;167(3):152-158. doi: 10.7326/M16-2733. Epub 2017 Jul 4. Ann Intern Med. 2017. PMID: 28672282

Similar articles

[Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].
Haemers I, Delvallée M. Haemers I, et al. Rev Med Brux. 2016;37(3):174-177. Rev Med Brux. 2016. PMID: 28525191 French.
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Na'amnih W, Adler A, Miller-Roll T, Cohen D, Carmeli Y. Na'amnih W, et al. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1281-1288. doi: 10.1007/s10096-018-3247-1. Epub 2018 Apr 7. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29627951
Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.
Chen Y, Rashid MU, Huang H, Fang H, Nord CE, Wang M, Weintraub A. Chen Y, et al. J Microbiol Immunol Infect. 2017 Aug;50(4):532-536. doi: 10.1016/j.jmii.2015.10.017. Epub 2015 Dec 1. J Microbiol Immunol Infect. 2017. PMID: 26698688
Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection.
Kufelnicka AM, Kirn TJ. Kufelnicka AM, et al. Clin Infect Dis. 2011 Jun 15;52(12):1451-7. doi: 10.1093/cid/cir201. Clin Infect Dis. 2011. PMID: 21628487 Review.
Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS. Cocanour CS. Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Surg Infect (Larchmt). 2011. PMID: 21767157 Review.

See all similar articles

Cited by

Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ, Cope JL, Wong MC, Petrosino JF, Chesnel L. Ajami NJ, et al. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02112-17. doi: 10.1128/AAC.02112-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29463537 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations